Oral Ondansetron Administration to Dehydrated Children in Pakistan: A Randomized Clinical Trial.
Pediatrics · 2019-11-06 · Randomised trial
Abstract
BACKGROUND: Ondansetron is an effective antiemetic employed to prevent vomiting in children with gastroenteritis in high-income countries; data from low- and middle-income countries are sparse. METHODS: We conducted a randomized, double-blind, placebo-controlled superiority trial in 2 pediatric emergency departments in Pakistan. Dehydrated children aged 6 to 60 months with ≥1 diarrheal (ie, loose or liquid) stool and ≥1 vomiting episode within the preceding 4 hours were eligible to participate. Participants received a single weight-based dose of oral ondansetron (8-15 kg: 2 mg; >15 kg: 4 mg) or identical placebo. The primary outcome was intravenous administration of ≥20 mL/kg over 4 hours of an isotonic fluid within 72 hours of random assignment. RESULTS: All 918 (100%) randomly assigned children completed follow-up. Intravenous rehydration was administered to 14.7% (68 of 462) and 19.5% (89 of 456) of those administered ondansetron and placebo, respectively (difference: -4.8%; 95% confidence interval [CI], -9.7% to 0.0%). In multivariable logistic regression analysis adjusted for other antiemetic agents, antibiotics, zinc, and the number of vomiting episodes in the preceding 24 hours, children administered ondansetron had lower odds of the primary outcome (odds ratio: 0.70; 95% CI, 0.49 to 1.00). Fewer children in the ondansetron, relative to the placebo group vomited during the observation period (difference: -12.9%; 95% CI, -18.0% to -7.8%). The median number of vomiting episodes (P < .001) was lower in the ondansetron group. CONCLUSIONS: Among children with gastroenteritis-associated vomiting and dehydration, oral ondansetron administration reduced vomiting and intravenous rehydration use. Ondansetron use may be considered to promote oral rehydration therapy success among dehydrated children in low- and middle-income countries.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antiemetics · Children · Low- and middle-income settings · Other drugs
Related articles
- Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children. (Acad Emerg Med, 2006)
- Oral ondansetron for gastroenteritis in a pediatric emergency department. (N Engl J Med, 2006)
- Systematic review with meta-analysis: ondansetron for vomiting in children with acute gastroenteritis. (Aliment Pharmacol Ther, 2016)
- Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis. (PLoS One, 2015)
- Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. (Cochrane Database Syst Rev, 2011)
- Oral Ondansetron Administration to Nondehydrated Children With Diarrhea and Associated Vomiting in Emergency Departments in Pakistan: A Randomized Controlled Trial. (Ann Emerg Med, 2019)